TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Roche Pharma Research and Early Development
Curated by ChEMBL
Roche Pharma Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 41nMAssay Description:Inhibition of RSV Long fusion protein assessed as protection against virus induced cytopathic effect in infected human Hep2 cells after 5 days by CCK...More data for this Ligand-Target Pair